You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
American Association for Clinical Chemistry
Improving healthcare through laboratory medicine
Home
|
Customer Service
|
Site Map
|
Cart
|
Login
About AACC
Members
Events
Government & Public Affairs
Resource Centers
Professional Development
Publications
AACC Store
>
Members
>
NACB - The AACC Academy
>
NACB Blog
Recent Posts
Newborn Screening for Severe Combined Immunodeficiency (SCID): Should it be performed?
Are reference change values more useful than population-based reference intervals?
Autoimmune diabetes and related conditions
Where Is the Hemoglobin S?
Categories
Cancer and Tumor Markers
Case Study
Clinical Translational Science/Proteomics
CVD/Markers/Risk Factors
Diabetes/Endocrinology
Government Affairs/Patient Safety
Immunology/Infectious Disease
Instrumentation/Technology
Management/Medical Informatics
Molecular Pathology and Genetics
New/Other Disease Markers
Nutrition
POC Testing
Renal/GI/Hepatic
Special Populations
TDM/Toxicology
Archives
Year
: 2013
May 2013
April 2013
March 2013
February 2013
January 2013
Year
: 2012
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
Year
: 2011
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
RSS Feed
NACB Blog
MicroRNAs as potential biomarkers: Is the future here?
1/22/2013 2:01 PM |
Comments (0)
Recommend (249)
By
Verena Gounden, MBChB, FCP, MMed and Zhen Zhao, PhD, DABCC
MicroRNAs (miRNAs) are short strands of RNA that act as post-transcriptional regulators. Research in various disease processes from cancer to cardiovascular disease has found that miRNAs play a role in disease pathogenesis and have potential as biomarkers and therapeutic agents. However, as with a...(
Read More
)
Posted at 1/22/2013 2:01 PM | Tags:
CVD/Markers/Risk Factors
Risk Management in the Clinical Laboratory
11/13/2012 1:34 PM |
Comments (0)
Recommend (417)
By
James H. Nichols, PhD, DABCC, FACB
The healthcare in the United States is a lot like dining out. Sometimes you can experience a restaurant with great service and have a fantastic meal, but other times, the food is cold or not what you ordered. In healthcare, patients can have a great experience, and other times errors occur. Incorr...(
Read More
)
Posted at 11/13/2012 1:34 PM | Tags:
CVD/Markers/Risk Factors
The International Normalized Ratio: How well do we understand this measurement?
9/4/2012 10:04 AM |
Comments (0)
Recommend (489)
By
Niel Harris, MD
The oral anticoagulant warfarin (also called coumadin) is a vitamin K antagonist that is widely used to prevent venous thrombosis. Warfarin inhibits the post-translational carboxylation of coagulation factors II, VII, IX and X. This diminishes the ability of these factors to interact with phospholi...(
Read More
)
Posted at 9/4/2012 10:04 AM | Tags:
CVD/Markers/Risk Factors
Lipoproteomics: Will Proteins Be More Important Than Cholesterol?
5/1/2012 9:08 AM |
Comments (2)
Recommend (490)
By
Andrew Hoofnagle, MD, PhD
Elevated plasma concentrations of LDL cholesterol lead to increased risk of cardiovascular disease and elevated plasma concentrations of HDL cholesterol represent a negative risk factor for cardiovascular disease. But why? Isn’t cholesterol just cholesterol? Our lipoproteins vary in size, structu...(
Read More
)
Posted at 5/1/2012 9:08 AM | Tags:
CVD/Markers/Risk Factors
1 - 4
About AACC
|
Members
|
Government & Public Affairs
|
Resource Centers
|
Professional Development
|
Publications
Home
|
Customer Service
|
Site Map
|
AACC Store
|
Login
Contact Us
|
Privacy Policy and Legal Disclaimer
|
Join AACC
©2013 American Association for Clinical Chemistry
1850 K Street, NW Suite 625
Washington, DC 20006
Phone: (800) 892-1400 | Fax: (202) 887-5093